Abiopharma

🔍 O'Connell Shawn M. (Executive)

Company: EnerSys (ENS)

Report Date: 2026-03-27

Detailed Transactions and Holdings:

• Acquired 3 shares of Common Stock (Direct)
  Date: 2026-03-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 71,480.97 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 4 shares of Common Stock (Direct)
  Date: 2026-03-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 71,485.38 | transaction_form_type: 4 | Footnotes: F3
• Acquired 9 shares of Common Stock (Direct)
  Date: 2026-03-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 71,494.59 | transaction_form_type: 4 | Footnotes: F4
• Acquired 6 shares of Common Stock (Direct)
  Date: 2026-03-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 71,500.94 | transaction_form_type: 4 | Footnotes: F5
• Acquired 39 shares of Common Stock (Direct)
  Date: 2026-03-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 71,539.47 | transaction_form_type: 4 | Footnotes: F6

Footnotes:

• F1: These shares were granted in the form of Restricted Stock Units ("RSUs"), in connection with the cash dividend paid on March 27, 2026, to stockholders of record as of March 13, 2026 (the "Dividend"), with respect to 1,822 unvested RSUs granted to the reporting person on August 12, 2022, and adjusted for previously declared and paid cash dividends. These RSUs will vest and are payable concurrent with the underlying RSUs.
• F2: Adjusted for previous arithmetic error.
• F3: These shares were granted in the form of RSUs, in connection with the Dividend, with respect to 2,702 unvested RSUs granted to the reporting person on August 11, 2023, and adjusted for previously declared and paid cash dividends. These RSUs will be payable concurrent with the underlying RSUs.
• F4: These shares were granted in the form of RSUs, in connection with the Dividend, with respect to 5,648 unvested RSUs granted to the reporting person on August 9, 2024, and adjusted for previously declared and paid cash dividends. These RSUs will be payable concurrent with the underlying RSUs.
• F5: These shares were granted in the form of RSUs, in connection with the Dividend, with respect to 3,895 unvested RSUs granted to the reporting person on November 8, 2024, and adjusted for previously declared and paid cash dividends. These RSUs will be payable concurrent with the underlying RSUs.
• F6: These shares were granted in the form of RSUs, in connection with the Dividend, with respect to 23,636 unvested RSUs granted to the reporting person on August 8, 2025, and adjusted for previously declared and paid cash dividends. These RSUs will be payable concurrent with the underlying RSUs.